Monday, July 15, 2024

AUTHOR NAME

Elham Talatghoushchi

487 POSTS
0 COMMENTS

Transdermal Technology Nutriband Receives Notice of Allowance for AVERSA™ Trademark

Nutriband Inc., a developer of transdermal pharmaceutical products, announced that it received a Notice of Allowance from the United States Patent and Trademark Office...

Hospital-at-Home Market Anticipated to Surge to $357.62 Billion by 2031

InsightAce Analytic Pvt. Ltd. has released an in-depth market assessment report on the Global Hospital-at-Home Market, currently valued at $16.44 billion in 2023. The...

Artificial Intelligence Act and the European Parliament’s New Legislation for Ethical and Transparent AI in Clinical Research

The European Parliament's new Artificial Intelligence (AI) Act is poised to drastically reshape the landscape of AI technologies within the European Union (EU). With...

Prescriber Code Error for Calcium Supplement in PBS Schedule

An error in the July 2024 PBS schedule has affected nurse practitioners' ability to prescribe Calcium carbonate 1.25 g (500 mg calcium) chewable tablets,...

Expansion of CTG PBS Co-payment Program Enhances Access

The July 2024 update to the PBS schedule includes a significant expansion of the Closing the Gap (CTG) PBS Co-payment Program, enhancing access to...

Enhancing Health Technology Assessment Policy and Methods in Australia

The Health Technology Assessment (HTA) Policy and Methods Review concluded on May 4, 2024, marking a significant step towards enhancing Australia's HTA policy and...

HIQA Publishes 50 Reports on Residential Centres for Older People

The Health Information and Quality Authority (HIQA) has published 50 inspection reports on residential centres for older people, covering inspections carried out between December...

Consultation on Newborn Screening Guidance Approaches

Canada's Drug Agency is currently seeking feedback on a discussion paper outlining proposed approaches to developing pan-Canadian guidance for newborn screening. This initiative, led...

Pfizer Advances Once-Daily Oral GLP-1 Agonist Danuglipron

Pfizer Inc. announced advancements in the development of a once-daily formulation of danuglipron, an oral GLP-1 receptor agonist. The ongoing pharmacokinetic study (NCT06153758) has...

Liquidity Crisis in Iran’s Pharmaceutical Sector: Challenges for Drug Manufacturers and Importers

Iran's pharmaceutical sector is facing significant liquidity challenges, affecting both drug manufacturers and importers. Gholamhossein Sadeghian, Director General of Drugs at the Food and...

Latest news